[HTML][HTML] Thyroid carcinoma: epidemiology, histology, and diagnosis
JP Shah - Clinical advances in hematology & oncology: H&O, 2015 - ncbi.nlm.nih.gov
The incidence of thyroid cancer has risen in recent years. In the United States, the incidence
increased at an annual rate of 5.4% in men and 6.5% in women from 2006 to 2010. 1 …
increased at an annual rate of 5.4% in men and 6.5% in women from 2006 to 2010. 1 …
[HTML][HTML] BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
L Jin, E Chen, S Dong, Y Cai, X Zhang, Y Zhou… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …
[引用][C] The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives
The new World Health Organization (WHO) classification of endocrine organs was
published in 2017 and several amendments were made to the classification of thyroid …
published in 2017 and several amendments were made to the classification of thyroid …
The BRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single …
R Elisei, D Viola, L Torregrossa… - The Journal of …, 2012 - academic.oup.com
Background: The BRAF V600E mutation, the most frequent genetic alteration in papillary
thyroid carcinoma (PTC), was demonstrated to be a poor prognostic factor. The aim of this …
thyroid carcinoma (PTC), was demonstrated to be a poor prognostic factor. The aim of this …
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading
The 5th edition of the Classification of Endocrine and Neuroendocrine Tumors has been
released by the World Health Organization (WHO). This timely publication integrates several …
released by the World Health Organization (WHO). This timely publication integrates several …
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta‐analysis
BACKGROUND: The effects of the BRAFV600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …